Pharmacy

An unnamed manager at Novartis sold $946,000 worth of company shares less than three weeks before a scandal involving manipulated data became public, according to Bloomberg. 

Between 2011 and 2017, Medicare could have saved $17.7 billion if generic versions of older medicines were prescribed instead of updated brand-name drugs launched by drugmakers to replace their older off-patent pills, according to a new study published in the…

The FDA has approved Rozlytrek, Roche's personalized cancer treatment that targets tumors with a specific genetic mutation.

Pfizer is recalling two lots of Relpax, tablets to treat migraines, due to bacterial contamination concerns.

PharmacyChecker.com, an online pharmacy verification service provider, accused several pharmaceutical associations of reaching agreements with online gatekeepers like Google and Bing to suppress its online presence, according to STAT. 

A former employee at Vasconi's Pharmacy in St. Helena, Calif., was arrested last week on felony charges of embezzlement, according to the Napa Valley Register.

Pharmacy benefit managers negotiated $18 billion worth of rebates from drugmakers in Medicare Part D and retained less than 1 percent of those rebates in 2016, according to a recent Government Accountability Office report.

Two lawmakers have accused three generic drugmakers of "coordinated obstruction" and "apparent efforts to stonewall" a 2014 probe into their pricing strategies, according to CNBC. 

The FDA has approved Pretomanid, an oral tablet for highly treatment-resistant forms of tuberculosis of the lungs. 

Page Bouchard was named senior vice president and chief scientific officer of AveXis, the gene therapy unit of Novartis wrapped in a scandal over manipulated data, according to Endpoints News. Mr. Bouchard is replacing two top scientists at the company,…